DE1617666A1 - Verfahren zur Herstellung von Erythrozyten-Praeparaten - Google Patents

Verfahren zur Herstellung von Erythrozyten-Praeparaten

Info

Publication number
DE1617666A1
DE1617666A1 DE19661617666 DE1617666A DE1617666A1 DE 1617666 A1 DE1617666 A1 DE 1617666A1 DE 19661617666 DE19661617666 DE 19661617666 DE 1617666 A DE1617666 A DE 1617666A DE 1617666 A1 DE1617666 A1 DE 1617666A1
Authority
DE
Germany
Prior art keywords
erythrocytes
suspension
tablets
sensitized
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19661617666
Other languages
German (de)
English (en)
Inventor
David Dr Dingwall
Jacobus Prof Polderman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Publication of DE1617666A1 publication Critical patent/DE1617666A1/de
Pending legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G01N33/76—Human chorionic gonadotropin including luteinising hormone, follicle stimulating hormone, thyroid stimulating hormone or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/554—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being a biological cell or cell fragment, e.g. bacteria, yeast cells
    • G01N33/555—Red blood cell
    • G01N33/556—Fixed or stabilised red blood cell

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Endocrinology (AREA)
  • Pathology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
DE19661617666 1965-07-28 1966-07-27 Verfahren zur Herstellung von Erythrozyten-Praeparaten Pending DE1617666A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL6509726A NL6509726A (ja) 1965-07-28 1965-07-28

Publications (1)

Publication Number Publication Date
DE1617666A1 true DE1617666A1 (de) 1971-04-01

Family

ID=19793749

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19661617666 Pending DE1617666A1 (de) 1965-07-28 1966-07-27 Verfahren zur Herstellung von Erythrozyten-Praeparaten

Country Status (4)

Country Link
BE (1) BE684720A (ja)
DE (1) DE1617666A1 (ja)
GB (1) GB1144215A (ja)
NL (1) NL6509726A (ja)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2546166A1 (de) * 1975-10-15 1977-04-28 Behringwerke Ag Gegerbte thrombozyten
CA1146852A (en) * 1979-01-31 1983-05-24 Koichi Kondo Reagent for latex agglutination
US5045446A (en) * 1988-08-26 1991-09-03 Cryopharm Corporation Lyophilization of cells
US4874690A (en) * 1988-08-26 1989-10-17 Cryopharm Corporation Lyophilization of red blood cells
WO1992010208A1 (en) * 1990-12-04 1992-06-25 Microtek Research And Development Ltd. Spray-dried antigenic products and method of preparation
CN113588501A (zh) * 2015-12-08 2021-11-02 生物马特里卡公司 降低红细胞沉降速率

Also Published As

Publication number Publication date
BE684720A (ja) 1967-01-30
GB1144215A (en) 1969-03-05
NL6509726A (ja) 1967-01-30

Similar Documents

Publication Publication Date Title
DE69121849T2 (de) Bindung von Liganden an Gold
DE69005800T2 (de) Verfahren zur herstellung von kleinen partikeln von biologisch aktiven molekülen.
DE2551208C3 (de) Verfahren zur Herstellung einer stabilen Erythrozyten-Präparation
DE2437845A1 (de) Pharmazeutisches, dispergierbares, sitosterine enthaltendes pulver und verfahren zu seiner herstellung
DE2546166A1 (de) Gegerbte thrombozyten
DE2322562C2 (de) Verfahren zur Bestimmung von Antigenen in einer Probe
DE2538388B2 (de) Verfahren zur Herstellung eines stabilen, nicht-radioaktiven Trägermaterials für mit radioaktiven Elementen markierte Diagnosemittel und seine Verwendung für mit Tc-99m-markierte Diagnosemittel
DE1961541A1 (de) Immunologisches Indikatorreagens
DE2219635A1 (de) Insulinprodukt
DE1617666A1 (de) Verfahren zur Herstellung von Erythrozyten-Praeparaten
DE1192367B (de) Verfahren zur Herstellung eines immunologischen Reagens
DE69631229T2 (de) Herstellung von virusinaktivierten intravenös injektierbaren Globulin aus Immunserum
DE1617672A1 (de) Verfahren zur Herstellung von fuer immunochemische Bestimmungen von Antigenen geeigneten Erythrocyten und deren Dosierungsformen
DE2850950C3 (de) Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren
DE1767899A1 (de) Verfahren zur Isolierung von Antigenen und Antikoerpern
DE2615336A1 (de) Verfahren zum gewinnen von leicht absorbierbarem steringlykosid
DE2551576B2 (de) Traeger fuer immunochemische messungen
DE2124123A1 (de) Polynucleotid und Verfahren zu deren Herstellung
EP1021198A1 (de) Flavonolignan-zubereitungen, insbesondere silymarin-zubereitungen
DE951228C (de) Verfahren zur Stabilisierung eines adrenocorticotropen Praeparates
DD202474A5 (de) Verfahren zur herstellung von antigenen, antikoerpern und deren komplexen
DE1165392B (de) Vitamine enthaltende Stoffe als Beimischung zu Futtermitteln
DE2132499C3 (de) Mittel zur Schwangerschaftsbestimmung und Verfahren zu dessen Herstellung
DE960579C (de) Verfahren zur Herstellung eines in der Hitze sterilisierbaren Adrenocorticotropin-Praeparates
DE1598859C (de) Verfahren zur Herstellung von Reagen zien für immunochemische Bestimmungen